price commentari better expect expect sale
even report result beat expect rais guidanc
compani abl grow face aggress competit maintain
price importantli facilit convers potenti increas price
open access greater patient popul icgm pathway acceler pipelin
innov see upsid number year oper leverag final show
remain buyer share despit run stock
given themat outlook cgm could inde penetr type
intens manag type coupl cgm market clearli acceler
last month increment confid reach
sale rais pt base unchang
sale estim assum net cash s/o
lot like sale beat consensu
compani show success leverag grow op ex versu sale growth
intern remain strong strength major
upsid price remain stabl volum growth remain strong
guidanc prudent conserv ahead launch contract
manag rais sale guidanc impli growth
kept gross margin op ex guidanc unchang view guidanc remain
conserv upsid surfac throughout year specif grew
face aggress competit thu see reason
price growth deceler back half
point call lot new nugget call one
focu icgm limit launch underway go well
calibr obviou benefit eas use applic garner lot
attent well compani expect full roll ada
read on-line june target date gap approv launch may
delay order bless consensu number deferral/upgrad
program place minim impact bullish rhetor around
price guidanc impli flat sensor price manag believ
room slight uptick price scenario and/or flat price enabl access
broader patient popul final believ icgm still underappreci
street everyth dxcm pipelin easier path market
key long term advantag compani
develop continu glucos monitor diabet manag
price close may
sale assum
net cash fulli dilut share
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
sourc compani report piper jaffray co estim
page
good gener incom expens net incom tax incom analysi gross gener breakdown durabl
thousand except per share
good sold
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
